National Cancer Center, Tokyo
Vitamin C supplementation might reduce frequency of common cold
Published in Pharma Law Weekly, March 21st, 2006
According to a recent report, researchers in Japan conducted a study "to investigate the relationship between the common cold and vitamin C supplementation [via a] double-blind, 5-year randomized controlled trial."
"A village in Akita prefecture, one of the regions in Japan with the highest mortality from gastric cancer [was studied]. Participants in annual screening programs for circulatory diseases conducted under the National Health and Welfare Services Law for the Aged, and diagnosed as having atrophic gastritis [were enrolled]. Of the 439 eligible subjects, 144 and 161 were...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly
Source: Pharma Law Weekly (2006-03-21)
More Articles from Pharma Law Weekly
- Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals reports loss of $0.56 per share - Amarin Corp. plc
Amarin posts quarterly loss of $0.10 per share - Arachnova Therapeutics Limited
Arachnova portfolio strengthened with new patents for MCI-225 - AstraZeneca
Economic impact of acute ischemic stroke highlighted in new study - Baylor College of Medicine, Houston
Ethics of signing on to the medical-industrial complex are examined - California Coalition for Compassionate Access
California group launched to support medical marijuana - More from this issue of Pharma Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
